Analysis of monoclonal antibodies to prostate-specific antigen: Reactivity with native and recombinant prostate-specific antigen

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 86-93

  Zhou, Z ^a   Barnett, T R ^a   Very, D L ^a   Ng, P C ^a   Pellegrino, C M ^a   Davis, G ^a   Belenky, A ^a   Allard, W J ^a   Yeung, Kwok K ^a  

^a BAYER CORPORATION   (United States)

Author keywords

ISOBM; Prostate cancer; Prostate specific antigen; TD 3 monoclonal antibodies; Tumor marker

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A5 6; MONOCLONAL ANTIBODY 2E9; MONOCLONAL ANTIBODY 2H11; MONOCLONAL ANTIBODY 4H5; MONOCLONAL ANTIBODY 5A10; MONOCLONAL ANTIBODY 94 6102; MONOCLONAL ANTIBODY 9B10; MONOCLONAL ANTIBODY E72; MONOCLONAL ANTIBODY E74; MONOCLONAL ANTIBODY E86; MONOCLONAL ANTIBODY E91; MONOCLONAL ANTIBODY F5; MONOCLONAL ANTIBODY H117; MONOCLONAL ANTIBODY H50; MONOCLONAL ANTIBODY M704; MONOCLONAL ANTIBODY MM1; MONOCLONAL ANTIBODY MP2; MONOCLONAL ANTIBODY PR1; MONOCLONAL ANTIBODY PR12; MONOCLONAL ANTIBODY PS101; MONOCLONAL ANTIBODY PS80; MONOCLONAL ANTIBODY PS98; MONOCLONAL ANTIBODY PSR217; MONOCLONAL ANTIBODY PSR222; MONOCLONAL ANTIBODY PSR233; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ANTIGEN BINDING; CONFERENCE PAPER; EPITOPE MAPPING; IMMUNOBLOTTING; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONFORMATION;

EID: 0032756230     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056535     Document Type: Conference Paper

References (14)

1. Watt WK, Lee PJ, Timkulu M, Chan WP, Loor R: Human prostate-specific antigen: Structure and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986;83:3166-3170.
2. Lilja H, Abrahamsson PA: Three predominant proteins secreted by the human prostate gland. Prostate 1980;12:29-38.
3. Christensson A, Laurel CB, Lilja H: Enzymatic activity of prostatic-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194: 755-763.
4. Armbruster DA: Prostate-specific antigen: Biochemistry, analytical methods and clinical application. Clin Chem 1993;39:181-195.
5. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tulikanen K, Alfthan 0: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51:222-226.
6. Leinonen J, Zhang W-M, Stenman UH: Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996;155:1099-1103.
7. Smith AJ, Scaletsky R: Future directions in tumor marker technology for prostate cancer. Prostatic Tumor Markers 1993;20:771-777.
8. Lilja H, Christensson A, Dahlen U, Matikainen M-T, Nilsson O, Pettersson K, Lövgren T: Prostate-specific antigen in human serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991;37:1618-1625.
9. Graves HCB, Kamarei M, Stamey TA: Identity of prostate specific antigen and the semen protein p30 purified by a rapid chromatography technique. J Urol 1990;144:1510-1515.
10. Zhou AM, Tewari PC, Bluestein BL, Caldwell GW, Larsen FL: Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39: 2483-2491.
11. Wu JT: Assays for prostate specific antigen (PSA): Problems and possible solutions. J Clin Lab Anal 1994; 8:51-52.
12. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, Lilja H, Oesterling JE: Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology 1995;45:729-744.
13. Karr JF, Kantor JA, Hand PH, Eggensperger DL, Schlom J: The presence of prostate specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res 1995;55:2455-2462.
14. Villoutreix BO, Getzoff ED, Griffin JH: A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci 1994;3:2033-2044.